Fractyl Health

Transformative Metabolic Therapies

Clinical study in patients who have lost at least 15% total body weight on GLP-1 drug therapy and wish to discontinue their GLP-1 drug without weight regain.

Obesity

If you have obesity, you could benefit from a clinical research study evaluating a non-drug procedure that may help you maintain body weight loss after stopping GLP-1 based drug therapy. REMAIN-1 is a pivotal clinical study that is currently enrolling across the United States. If you are interested in participating in a study that will evaluate the potential for Revita to help maintain weight loss (in conjunction with diet and exercise) after stopping GLP-1 based drugs, REMAIN-1 may be right for you.